Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 May;85(1):197–203. doi: 10.1111/j.1476-5381.1985.tb08847.x

Forskolin: its effects on potassium-evoked release of vasopressin from the rat neurohypophysis.

D Bowman, D B Hope
PMCID: PMC1916769  PMID: 2992649

Abstract

The effect of forskolin, added either before or 5 min after the onset of potassium-evoked release of vasopressin from isolated neurointermediate lobes of the rat has been investigated. A low concentration of forskolin (1 microM), added before stimulation, enhanced the potassium-evoked release of vasopressin throughout two successive 5 min periods of stimulation. Higher concentrations of forskolin (10-80 microM) produced no effect on the potassium-evoked release of hormone during the first 5 min of stimulation, but inhibited release during the second 5 min period. When added 5 min after the onset of potassium stimulation, forskolin (1-80 microM) reduced the amount of vasopressin released during the remaining 5 min of stimulation. Forskolin produced a concentration-dependent increase in cyclic AMP during both the control and potassium stimulation periods. The amount of cyclic AMP generated by forskolin during potassium stimulation was less than that produced during the corresponding control periods.

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böhlen P., Stein S., Dairman W., Udenfriend S. Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys. 1973 Mar;155(1):213–220. doi: 10.1016/s0003-9861(73)80023-2. [DOI] [PubMed] [Google Scholar]
  2. DOUGLAS W. W., POISNER A. M. CALCIUM MOVEMENT IN THE NEUROHYPOPHYSIS OF THE RAT AND ITS RELATION TO THE RELEASE OF VASOPRESSIN. J Physiol. 1964 Jul;172:19–30. doi: 10.1113/jphysiol.1964.sp007400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DOUGLAS W. W., POISNER A. M. STIMULUS-SECRETION COUPLING IN A NEUROSECRETORY ORGAN: THE ROLE OF CALCIUM IN THE RELEASE OF VASOPRESSIN FROM THE NEUROHYPOPHYSIS. J Physiol. 1964 Jul;172:1–18. doi: 10.1113/jphysiol.1964.sp007399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dartt D. A., Torp-Pedersen C., Thorn N. A. Effects of Ca2+ and calmodulin on cyclic nucleotide metabolism in neurosecretosomes isolated from ox neurohypophyses. Brain Res. 1981 Jan 5;204(1):121–128. doi: 10.1016/0006-8993(81)90656-9. [DOI] [PubMed] [Google Scholar]
  5. Ebstein R. P., Seamon K., Creveling C. R., Daly J. W. Release of norepinephrine from brain vesicular preparations: effects of an adenylate cyclase activator, forskolin, and a phosphodiesterase inhibitor. Cell Mol Neurobiol. 1982 Sep;2(3):179–192. doi: 10.1007/BF00711146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. González A., Aranda E., Mezzano D., Garrido J. Effects of diterpene forskolin on the release reaction and protein phosphorylation of human platelets. Cell Biochem Funct. 1983 Oct;1(3):179–185. doi: 10.1002/cbf.290010311. [DOI] [PubMed] [Google Scholar]
  7. Hathaway D. R., Eaton C. R., Adelstein R. S. Regulation of human platelet myosin light chain kinase by the catalytic subunit of cyclic AMP-dependent protein kinase. Nature. 1981 May 21;291(5812):252–256. doi: 10.1038/291252a0. [DOI] [PubMed] [Google Scholar]
  8. Le Peuch C. J., Haiech J., Demaille J. G. Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cyclic adenosine monophosphate dependent and calcium--calmodulin-dependent phosphorylations. Biochemistry. 1979 Nov 13;18(23):5150–5157. doi: 10.1021/bi00590a019. [DOI] [PubMed] [Google Scholar]
  9. Markstein R., Digges K., Marshall N. R., Starke K. Forskolin and the release of noradrenaline in cerebrocortical slices. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jan;325(1):17–24. doi: 10.1007/BF00507049. [DOI] [PubMed] [Google Scholar]
  10. Mathison R., Lederis K. A mechanism for adenosine 3',5'-monophosphate regulation of vasopressin secretion. Endocrinology. 1980 Mar;106(3):842–848. doi: 10.1210/endo-106-3-842. [DOI] [PubMed] [Google Scholar]
  11. Metzger H., Lindner E. The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneimittelforschung. 1981;31(8):1248–1250. [PubMed] [Google Scholar]
  12. Muller M. J., Baer H. P. Relaxant effects of forskolin in smooth muscle. Role of cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol. 1983 Feb;322(1):78–82. doi: 10.1007/BF00649356. [DOI] [PubMed] [Google Scholar]
  13. Nestler E. J., Greengard P. Protein phosphorylation in the brain. Nature. 1983 Oct 13;305(5935):583–588. doi: 10.1038/305583a0. [DOI] [PubMed] [Google Scholar]
  14. Rabe C. S., Schneider J., McGee R., Jr Enhancement of depolarization-dependent neurosecretion from PC12 cells by forskolin-induced elevation of cyclic AMP. J Cyclic Nucleotide Res. 1982;8(6):371–384. [PubMed] [Google Scholar]
  15. Racké K., Ritzel H., Trapp B., Muscholl E. Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids. Naunyn Schmiedebergs Arch Pharmacol. 1982 Apr;319(1):56–65. doi: 10.1007/BF00491479. [DOI] [PubMed] [Google Scholar]
  16. Racké K., Rothländer M., Muscholl E. Isoprenaline and forskolin increase evoked vasopressin release from rat pituitary. Eur J Pharmacol. 1982 Aug 13;82(1-2):97–100. doi: 10.1016/0014-2999(82)90560-x. [DOI] [PubMed] [Google Scholar]
  17. Rasmussen H., Barrett P. Q. Calcium messenger system: an integrated view. Physiol Rev. 1984 Jul;64(3):938–984. doi: 10.1152/physrev.1984.64.3.938. [DOI] [PubMed] [Google Scholar]
  18. Rinaldi M. L., Capony J. P., Demaille J. G. The cyclic AMP-dependent modulation of cardiac sarcolemmal slow calcium channels. J Mol Cell Cardiol. 1982 May;14(5):279–289. doi: 10.1016/0022-2828(82)90206-1. [DOI] [PubMed] [Google Scholar]
  19. Rinaldi M. L., Le Peuch C. J., Demaille J. G. The epinephrine-induced activation of the cardiac slow Ca2+ channel is mediated by the cAMP-dependent phosphorylation of calciductin, a 23 000 Mr sarcolemmal protein. FEBS Lett. 1981 Jul 6;129(2):277–281. doi: 10.1016/0014-5793(81)80183-4. [DOI] [PubMed] [Google Scholar]
  20. Salacinski P., Hope J., McLean C., Clement-Jones V., Sykes J., Price J., Lowry P. J. A new simple method which allows theoretical incorporation of radio-iodine into proteins and peptides without damage [proceedings]. J Endocrinol. 1979 May;81(2):131P–131P. [PubMed] [Google Scholar]
  21. Seamon K. B., Daly J. W. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res. 1981;7(4):201–224. [PubMed] [Google Scholar]
  22. Seamon K., Daly J. W. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem. 1981 Oct 10;256(19):9799–9801. [PubMed] [Google Scholar]
  23. Stengel D., Guenet L., Desmier M., Insel P., Hanoune J. Forskolin requires more than the catalytic unit to activate adenylate cyclase. Mol Cell Endocrinol. 1982 Nov-Dec;28(3):681–690. doi: 10.1016/0303-7207(82)90155-1. [DOI] [PubMed] [Google Scholar]
  24. Vale M. R., Baker R. V., Hope D. B. Phosphodiesterase activities for cyclic nucleotides in nerve endings from the bovine posterior pituitary gland. J Neurochem. 1984 Feb;42(2):377–383. doi: 10.1111/j.1471-4159.1984.tb02688.x. [DOI] [PubMed] [Google Scholar]
  25. Vale M. R., Hope D. B. Cyclic nucleotides and the release of vasopressin from the rat posterior pituitary gland. J Neurochem. 1982 Aug;39(2):569–573. doi: 10.1111/j.1471-4159.1982.tb03983.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES